Efficacy and Safety of an Intelligent Insulin-Dosing Decision Support System for Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

Also called NCT07291804

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 140 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07291804
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07291804. Randomized; single masking; primary purpose treatment. Start 2025-03-01 (actual); primary completion 2025-12-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of an Intelligent Insulin-Dosing Decision Support System for Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled Study
Condition
Diabetes Mellitus,Type 2
Intervention (Device)
Intelligent Insulin-Dosing Decision Support System
Lead sponsor
Third Affiliated Hospital, Sun Yat-Sen University (class: other)

Record details

Record id
cardio:ct-nct07291804
Content hash
a829b3a66e4de486a0352a6acc6dfedbdfdac6f7ed35eda082e6950c34c5d6aa